Fieldfisher has advised biotechnology company, Link Biologics, on their co-equity fundraising for their innovative dry eye disease (DED) program in partnership with Théa Open Innovation, assisted…
This content is for Standard 1 Year members only. LoginJoin Now
Author: Paolo Bossi
…
This content is for Standard 1 Year members only. LoginJoin Now